Cardiometabolic Care-team Integration Improves Outcomes in Diabetes
Launched by SCRIPPS WHITTIER DIABETES INSTITUTE · Jun 17, 2018
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients with type 1 and type 2 diabetes
- Exclusion Criteria:
- • None
About Scripps Whittier Diabetes Institute
The Scripps Whittier Diabetes Institute is a leading clinical research organization dedicated to advancing the understanding and treatment of diabetes and related metabolic disorders. As a part of the renowned Scripps Research network, the Institute focuses on innovative research, cutting-edge clinical trials, and the development of effective therapeutic interventions. With a multidisciplinary team of experts in endocrinology, nutrition, and behavioral health, the Scripps Whittier Diabetes Institute is committed to improving patient outcomes through rigorous scientific inquiry and a patient-centered approach to care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials